Trial Outcomes & Findings for A Clinical Study to Compare Professional Treatments for Dentinal Hypersensitivity (NCT NCT03405259)

NCT ID: NCT03405259

Last Updated: 2019-06-17

Results Overview

The Schiff Sensitivity Scale was assessed for each test tooth via an evaporative air challenge. The examiner recorded the Schiff Index score corresponding to the response to the air challenge. The Schiff Index Sensitivity scale is scored as follows- 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subject responds to stimulus and requests discontinuation or moves form stimulus, 3: tooth/subject responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A negative change from Baseline score represents a decrease in sensitivity from baseline.The mean change from Baseline was calculated for this measure.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

22 participants

Primary outcome timeframe

Within 5 minutes after treatment was applied

Results posted on

2019-06-17

Participant Flow

Participant milestones

Participant milestones
Measure
Super Seal® Desensitizer
Professionally Applied Super Seal® Desensitizer: Single dose professional application.
Acclean® Fluoride Varnish
Professionally Applied Acclean® Fluoride Varnish: Single dose professional application.
Overall Study
STARTED
11
11
Overall Study
COMPLETED
11
11
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

A Clinical Study to Compare Professional Treatments for Dentinal Hypersensitivity

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Super Seal® Desensitizer
n=11 Participants
Professionally Applied Super Seal® Desensitizer: Single dose professional application.
Acclean® Fluoride Varnish
n=11 Participants
Professionally Applied Acclean® Fluoride Varnish: Single dose professional application.
Total
n=22 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Age, Categorical
Between 18 and 65 years
11 Participants
n=93 Participants
11 Participants
n=4 Participants
22 Participants
n=27 Participants
Age, Categorical
>=65 years
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Age, Continuous
44.6 years
STANDARD_DEVIATION 9.84 • n=93 Participants
48.1 years
STANDARD_DEVIATION 19.71 • n=4 Participants
46.4 years
STANDARD_DEVIATION 15.30 • n=27 Participants
Sex: Female, Male
Female
9 Participants
n=93 Participants
11 Participants
n=4 Participants
20 Participants
n=27 Participants
Sex: Female, Male
Male
2 Participants
n=93 Participants
0 Participants
n=4 Participants
2 Participants
n=27 Participants
Race/Ethnicity, Customized
Asian Oriental
1 Participants
n=93 Participants
1 Participants
n=4 Participants
2 Participants
n=27 Participants
Race/Ethnicity, Customized
Black
0 Participants
n=93 Participants
1 Participants
n=4 Participants
1 Participants
n=27 Participants
Race/Ethnicity, Customized
Caucasian
8 Participants
n=93 Participants
9 Participants
n=4 Participants
17 Participants
n=27 Participants
Race/Ethnicity, Customized
Hispanic
2 Participants
n=93 Participants
0 Participants
n=4 Participants
2 Participants
n=27 Participants
Region of Enrollment
United States
11 participants
n=93 Participants
11 participants
n=4 Participants
22 participants
n=27 Participants

PRIMARY outcome

Timeframe: Within 5 minutes after treatment was applied

Population: Twenty-two (22) subjects received study product and completed the study.

The Schiff Sensitivity Scale was assessed for each test tooth via an evaporative air challenge. The examiner recorded the Schiff Index score corresponding to the response to the air challenge. The Schiff Index Sensitivity scale is scored as follows- 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subject responds to stimulus and requests discontinuation or moves form stimulus, 3: tooth/subject responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A negative change from Baseline score represents a decrease in sensitivity from baseline.The mean change from Baseline was calculated for this measure.

Outcome measures

Outcome measures
Measure
Super Seal® Desensitizer
n=11 Participants
Professionally Applied Super Seal® Desensitizer: Single dose professional application.
Acclean® Fluoride Varnish
n=11 Participants
Professionally Applied Acclean® Fluoride Varnish: Single dose professional application.
Change From Baseline Air Challenge
-0.55 Units on a scale
Standard Deviation 0.69
-0.95 Units on a scale
Standard Deviation 0.93

PRIMARY outcome

Timeframe: Within 5 minutes after treatment was applied

Population: Twenty-two (22) subjects received product and completed the study.

Visual Analog Scale (VAS) - subjects are asked to look at a VAS and designate the level of hypersensitivity they experienced as a result of the thermal and water challenges using a continuum scale of 0 = No tooth pain up to 100 = Worst tooth pain ever experienced. A negative change from Baseline score represents a decrease in sensitivity from baseline.

Outcome measures

Outcome measures
Measure
Super Seal® Desensitizer
n=11 Participants
Professionally Applied Super Seal® Desensitizer: Single dose professional application.
Acclean® Fluoride Varnish
n=11 Participants
Professionally Applied Acclean® Fluoride Varnish: Single dose professional application.
Change From Baseline Visual Analog Scale
-17.60 Units on a scale
Standard Deviation 21.32
-19.55 Units on a scale
Standard Deviation 25.15

Adverse Events

Super Seal® Desensitizer

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Acclean® Fluoride Varnish

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Clinical Trial Manager

The Procter & Gamble Company

Phone: 513-622-2489

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: OTHER